Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
The FDA has launched an investigation into reports of T-cell malignancies in patients treated with autologous chimeric antigen receptor (CAR) T-cell therapies targeting B-cell maturation
The FDA has rejected specialty pharma and generics maker Amneal Pharmaceuticals’ extended-release capsule for Parkinson’s disease, which combines two drugs that have long been used